drugset / Trial / NCT06205329
Study of WPV01 in Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WPV01 and WPV01 Co-administrated With Ritonavir in Healthy Adult Subjects.
Timeline
- Start
- 2022-10-03
- Primary completion
- 2023-03-11
- Completion
- 2023-07-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ritonavir | Other / unclassified | — | — |
| Subject | WPV01 | Unknown | — | — |
Indications
No indication recorded.